News for Merus N.V. (MRUS)

Published at

Mar 3, 2025 2:00 PM

by gurufocus.com

mixed

mixed

Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results

PR NewswireNEW HAVEN, Conn., March 3, 2025 Announced acceptance and Priority Review by the United States Food and Drug Administration (FDA) of the new drug

BHVN REGN34.SA REGN.MX REGN MRUS 0R2M.L

Read more →
Published at

Feb 28, 2025 1:05 AM

by zacks.com

negative

negative

Merus N.V. (MRUS) Reports Q4 Loss, Lags Revenue Estimates

Merus (MRUS) delivered earnings and revenue surprises of 56.84% and 22.35%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

MRUS

Read more →
Published at

Feb 27, 2025 11:00 PM

by gurufocus.com

positive

positive

Merus Announces Financial Results for the Fourth Quarter and Full Year 2024 and Provides Business Update

- Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC and petosemtamab monotherapy in 2/3L r/m HNSCC

OPHLY OPHLF MRUS LLY.MX LLY.DE LLY.BA LLY LILY34.SA INCY I1NC34.SA GILDD.BA 4528.T 300558.SZ 0Q1G.L 0J9P.L

Read more →
Published at

Feb 27, 2025 10:30 PM

by manilatimes.net

positive

positive

Merus Announces Financial Results for the Fourth Quarter and Full Year 2024 and Provides Business Update

**media[552869]**

OPHLY OPHLF MRUS LLY.MX LLY.DE LLY.BA LLY LILY34.SA INCY I1NC34.SA GILDD.BA GILD 4528.T 300558.SZ 0Q1G.L 0J9P.L

Read more →
Published at

Feb 26, 2025 1:05 AM

by gurufocus.com

positive

positive

COMMODORE CAPITAL LP Acquires 5,825,000 Shares in Solid Biosciences Inc

On February 18, 2025, COMMODORE CAPITAL LP (Trades, Portfolio) made a significant move by acquiring 5,825,000 shares of Solid Biosciences Inc (NASDAQ: SLDB) at

XENE SLDB PCVX NUVL MRUS

Read more →
Published at

Feb 25, 2025 2:14 PM

by manilatimes.net

positive

positive

Merus to Present at Upcoming Investor Conferences

**media[549738]**

MRUS COWNL COWN

Read more →
Published at

Feb 25, 2025 2:00 PM

by gurufocus.com

positive

positive

Merus to Present at Upcoming Investor Conferences

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Merus N.V. ( MRUS), a clinical-stage oncology company developing innovative,

MRUS

Read more →
Published at

Feb 19, 2025 3:00 PM

by prweb.com

mixed

mixed

Ambrosia Biosciences Further Strengthens Board of Directors with Appointment of Jason Haddock

/PRNewswire-PRWeb/ -- Ambrosia Biosciences Inc. ("Ambrosia"), today announced the appointment of Jason Haddock to the Board of Directors and as Chair of the...

SGEN 0A8R.L PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE MRUS

Read more →
Published at

Feb 18, 2025 2:00 PM

by gurufocus.com

positive

positive

Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma

This marks the second BTD for petosemtamab in HNSCC UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. ( MRUS), a c

MRUS

Read more →
Published at

Feb 18, 2025 2:00 PM

by gurufocus.com

mixed

mixed

Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company's Growth

-- Mr. Iwicki Brings Track Record of Operational Excellence and Significant Expertise in PAH and Cardiovascular Diseases -- -- Amit Munshi Appointed Chai

MRUS IKT AMGN AKRO PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE ARNA 0S54.L

Read more →
Published at

Feb 14, 2025 5:31 PM

by gurufocus.com

positive

positive

Lynx1 Capital Management LP Increases Stake in Allogene Therapeutics Inc

On December 31, 2024, Lynx1 Capital Management LP (Trades, Portfolio) made a significant move by acquiring an additional 4,672,349 shares of Allogene Therapeuti

STOK MRUS CCCC ALLO

Read more →
Published at

Feb 13, 2025 2:06 PM

by benzinga.com

mixed

mixed

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Fortis (NYSE:FTS), GE Vernova (NYSE:GEV)

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiation...

VKTX 0VQA.L FTS MRUS

Read more →
Published at

Feb 13, 2025 2:00 PM

by gurufocus.com

positive

positive

Merus to Present at Citi's 2025 Virtual Oncology Leadership Summit

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Merus N.V. ( MRUS), a clinical-stage oncology company developing innovative,

MRUS

Read more →
Published at

Feb 5, 2025 11:19 PM

by manilatimes.net

positive

positive

New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer

**media[533490]**

MRUS

Read more →
Published at

Jan 20, 2025 11:08 AM

by seekingalpha.com

positive

positive

Time To Upgrade Merus N.V. To A 'Buy' After The Recent Selloff (NASDAQ:MRUS)

Merus is a buy with Bizengri approval for NRG1+ cancers, Petosemtamab's potential, and partnership with BHVN for oncology applications. Learn more on MRUS stock here.

MRUS

Read more →
Published at

Jan 17, 2025 5:08 PM

by insidermonkey.com

positive

positive

Merus N.V. (MRUS): The Biotech Stock with Biggest Upside Potential

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Merus N.V.

MRUS

Read more →
Published at

Jan 13, 2025 8:37 AM

by seekingalpha.com

positive

positive

Merus and Biohaven to co-develop three novel bispecific ADC programs (NASDAQ:MRUS)

Biohaven (BHVN) and Merus N.V. (MRUS) announced a collaboration to co-develop three novel bispecific antibody drug conjugates, advancing ADC research.

MRUS

Read more →
Published at

Jan 13, 2025 2:08 AM

by investing.com

positive

positive

Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs By Investing.com

Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs

MRUS

Read more →
Published at

Jan 10, 2025 6:26 PM

by benzinga.com

positive

positive

TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday - Merus (NASDAQ:MRUS), Microvast Holdings (NASDAQ:MVST)

U.S. stocks were lower, with the Dow Jones index falling over 700 points on Friday. Shares of TD Synnex Corp SNX rose sharply in today's session after the comp...

TNKN.MX TNK TALO RPRX PCRX MVST MRUS 0EAQ.L

Read more →
Published at

Jan 7, 2025 3:35 PM

by insidermonkey.com

mixed

mixed

10 Jim Cramer Stocks to Watch in 2025

Jim Cramer in a latest program on CNBC commented on the bearish start of 2025 and said being a bear in the market is “easy” because when the stocks rise no one would remember your outlook but if they...

TLN PTC MRUS INTC.MX INL.DE HNRG DOV DCYHY DCYHF BLQA.DE BLK.MX BLK AAON 0QZZ.L XP INTCD.BA INTCCL.SN INTC.SN INTC INCO.BR CVSGF

Read more →